First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial
Surviving Life-Threatening Lung Cancer: Lessons Learned
Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset
JAK Inhibitors Reduce Thromboembolic Risk in Myeloproliferative Neoplasm Therapy